ShuYu Civilian Pharmacy Corp., Ltd.

SZSE:301017 Rapport sur les actions

Capitalisation boursière : CN¥5.5b

ShuYu Civilian Pharmacy Résultats passés

Passé contrôle des critères 0/6

ShuYu Civilian Pharmacy's earnings have been declining at an average annual rate of -15.6%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 22.2% per year.

Informations clés

-15.6%

Taux de croissance des bénéfices

-10.1%

Taux de croissance du BPA

Consumer Retailing Croissance de l'industrie12.8%
Taux de croissance des recettes22.2%
Rendement des fonds propres-2.1%
Marge nette-0.4%
Dernière mise à jour des bénéfices30 Sep 2024

Mises à jour récentes des performances passées

Recent updates

ShuYu Civilian Pharmacy (SZSE:301017) Seems To Be Using A Lot Of Debt

Oct 03
ShuYu Civilian Pharmacy (SZSE:301017) Seems To Be Using A Lot Of Debt

A Piece Of The Puzzle Missing From ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) 25% Share Price Climb

Sep 06
A Piece Of The Puzzle Missing From ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) 25% Share Price Climb

ShuYu Civilian Pharmacy (SZSE:301017) Could Be Struggling To Allocate Capital

Jul 25
ShuYu Civilian Pharmacy (SZSE:301017) Could Be Struggling To Allocate Capital

ShuYu Civilian Pharmacy Corp., Ltd. (SZSE:301017) Shares May Have Slumped 32% But Getting In Cheap Is Still Unlikely

Jun 21
ShuYu Civilian Pharmacy Corp., Ltd. (SZSE:301017) Shares May Have Slumped 32% But Getting In Cheap Is Still Unlikely

ShuYu Civilian Pharmacy (SZSE:301017) Use Of Debt Could Be Considered Risky

Jun 20
ShuYu Civilian Pharmacy (SZSE:301017) Use Of Debt Could Be Considered Risky

These 4 Measures Indicate That ShuYu Civilian Pharmacy (SZSE:301017) Is Using Debt Extensively

Mar 04
These 4 Measures Indicate That ShuYu Civilian Pharmacy (SZSE:301017) Is Using Debt Extensively

Ventilation des recettes et des dépenses

Comment ShuYu Civilian Pharmacy gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

SZSE:301017 Recettes, dépenses et bénéfices (CNY Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Sep 249,735-422,4430
30 Jun 249,748182,4200
31 Mar 249,558792,3970
31 Dec 239,1911332,2820
30 Sep 239,1102612,1820
30 Jun 238,6942572,0580
31 Mar 238,3082441,9190
01 Jan 237,8232291,8320
30 Sep 226,8541351,6570
30 Jun 226,2321391,5580
31 Mar 225,7241271,4560
01 Jan 225,3221151,3290
30 Sep 215,0182031,1550
30 Jun 214,8712331,0640
31 Mar 214,7052411,0600
31 Dec 204,6402161,0330
31 Dec 193,4671119540
31 Dec 182,8881138320

Des revenus de qualité: 301017 is currently unprofitable.

Augmentation de la marge bénéficiaire: 301017 is currently unprofitable.


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: 301017 is unprofitable, and losses have increased over the past 5 years at a rate of 15.6% per year.

Accélération de la croissance: Unable to compare 301017's earnings growth over the past year to its 5-year average as it is currently unprofitable

Bénéfices par rapport au secteur d'activité: 301017 is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (6%).


Rendement des fonds propres

ROE élevé: 301017 has a negative Return on Equity (-2.09%), as it is currently unprofitable.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé